Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Safety Profile of Combining Bupropion and GLP-1 Medications Published clinical experience shows that bupropion and semaglutide can coexist in the same treatment regimen without major adverse events when prescribed by a clinician who reviews full medication history
Millions of people are now taking GLP-1 receptor agonists, primarily for weight loss, and demand has exploded worldwide
When expanding trial eligibility criteria to reflect broader patient populations typically encountered in clinical practice, we identified 453,201 individuals initiating semaglutide or sitagliptin (expanding SUSTAIN-6 eligibility) and 136,089 initiating tirzepatide or dulaglutide (expanding SURPASS-CVOT eligibility)
Most major Canadian insurers (Manulife, Canada Life, Blue Cross, GreenShield) now have Wegovy on their prior authorization lists, meaning your doctor must submit documentation proving the medication is medically necessary
